Essex Bio-Technology's market cap is currently HK$1.62B. The company's EPS TTM is HK$0.463; its P/E ratio is 6.15; and it has a dividend yield of 3.68%. Essex Bio-Technology is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	HK$ 1.71B	HK$ 1.32B	HK$ 1.64B	HK$ 978.11M	HK$ 1.28B
Gross Profit	HK$ 1.54B	HK$ 1.19B	HK$ 1.40B	HK$ 793.83M	HK$ 1.03B
Operating Income	HK$ 310.33M	HK$ 278.05M	HK$ 435.58M	HK$ 237.40M	HK$ 343.35M
EBITDA	HK$ 418.38M	HK$ 313.54M	HK$ 436.65M	HK$ 279.50M	HK$ 386.15M
Net Income	HK$ 275.26M	HK$ 225.41M	HK$ 345.97M	HK$ 218.93M	HK$ 302.50M
Balance Sheet
Cash & Short-Term Investments	HK$ 515.03M	HK$ 543.49M	HK$ 671.35M	HK$ 599.80M	HK$ 483.93M
Total Assets	HK$ 2.83B	HK$ 2.71B	HK$ 2.86B	HK$ 2.42B	HK$ 2.08B
Total Debt	HK$ 294.02M	HK$ 489.73M	HK$ 565.19M	HK$ 562.77M	HK$ 369.30M
Net Debt	HK$ -215.82M	HK$ -53.75M	HK$ -106.15M	HK$ -37.01M	HK$ -104.05M
Total Liabilities	HK$ 903.78M	HK$ 981.03M	HK$ 1.13B	HK$ 995.15M	HK$ 880.80M
Stockholders' Equity	HK$ 1.92B	HK$ 1.73B	HK$ 1.73B	HK$ 1.43B	HK$ 1.20B
Cash Flow
Free Cash Flow	HK$ 211.16M	HK$ 99.87M	HK$ 164.63M	HK$ -18.40M	HK$ 67.03M
Operating Cash Flow	HK$ 339.21M	HK$ 382.79M	HK$ 409.16M	HK$ 299.24M	HK$ 232.86M
Investing Cash Flow	HK$ -54.34M	HK$ -302.03M	HK$ -280.08M	HK$ -343.27M	HK$ -179.60M
Financing Cash Flow	HK$ -309.92M	HK$ -169.11M	HK$ -73.13M	HK$ 149.49M	HK$ 113.35M

Currency in HKD

Essex Bio-Technology Earnings and Revenue History

Income Statement >

Essex Bio-Technology Debt to Assets

Balance Sheet >

Essex Bio-Technology Cash Flow

Cash Flow >

Essex Bio-Technology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing